Recent Data Regarding Treatment for Hepatorenal Syndrome
By: Madaline Spencer| Published on: Dec 27, 2024
https://checkrare.com/recent-data-regarding-treatment-for-hepatorenal-syndrome/
NDA Submission of Paltusotine for Acromegaly
Alan Krasner, MD, Chief Medical Officer of Crinetics Pharmaceuticals, discusses the new drug application (NDA) submission of paltusotine for treating acromegaly.
NDA Submission of Paltusotine for Acromegaly
By: Madaline Spencer| Published on: Dec 23, 2024
https://checkrare.com/nda-submission-of-paltusotine-for-acromegaly/
Symptom Burden of Primary Biliary Cholangitis
Carol Roberts, President, The PBCers Organization, discusses the symptom burden of primary biliary cholangitis (PBC).
Symptom Burden of Primary Biliary Cholangitis
By: Madaline Spencer| Published on: Dec 20, 2024
https://checkrare.com/symptom-burden-of-primary-biliary-cholangitis/
African American with Huntington’s Disease Explains Her Diagnostic Journey
Tanita Allen, a patient advocate with Huntington disease, discusses her diagnostic journey and advocacy work.
African American with Huntington’s Disease Explains Her Diagnostic Journey
By: Madaline Spencer| Published on: Dec 19, 2024
https://checkrare.com/african-american-with-huntingtons-disease-explains-her-diagnostic-journey/
Tardive Dyskinesia Strongly Impacts Quality of Life: Data from the IMPACT-TD Registry
Rakesh Jain, MD, MPH, Clinical Professor of Psychiatry, discusses tardive dyskinesia (TD) data from the IMPACT-TD Registry study.
Tardive Dyskinesia Strongly Impacts Quality of Life: Data from the IMPACT-TD Registry
By: Madaline Spencer| Published on: Dec 18, 2024
https://checkrare.com/tardive-dyskinesia-strongly-impacts-quality-of-life-data-from-the-impact-td-registry/
No hay comentarios:
Publicar un comentario